{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:21:38Z","timestamp":1750537298957},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T00:00:00Z","timestamp":1243296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10072-009-0097-8","type":"journal-article","created":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T16:59:42Z","timestamp":1243270782000},"page":"291-294","source":"Crossref","is-referenced-by-count":4,"title":["Predictable variables for short- and long-term botulinum toxin treatment response in patients with cervical dystonia"],"prefix":"10.1007","volume":"30","author":[{"given":"Andre C.","family":"Felicio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clecio","family":"Godeiro-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"de Carvalho Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderci","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia M. A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique B.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,26]]},"reference":[{"key":"97_CR1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10072-008-1033-z","volume":"29","author":"C Boccagni","year":"2008","unstructured":"Boccagni C, Carpaneto J, Micera S et al (2008) Motion analysis in cervical dystonia. Neurol Sci 29:375\u2013381","journal-title":"Neurol Sci"},{"key":"97_CR2","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/mds.20670","volume":"20","author":"IM Skogseid","year":"2005","unstructured":"Skogseid IM, Roislien J, Claussen B et al (2005) Long-term botulinum toxin increases employment rate in patients with cervical dystonia. Mov Disord 20:1604\u20131609","journal-title":"Mov Disord"},{"key":"97_CR3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","volume":"20","author":"D Truong","year":"2005","unstructured":"Truong D, Duane DD, Jankovic J et al (2005) Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 20:783\u2013791","journal-title":"Mov Disord"},{"key":"97_CR4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archneur.1991.00530240057020","volume":"48","author":"J Jankovic","year":"1991","unstructured":"Jankovic J, Schwartz KS (1991) Clinical correlates of response to botulinum toxin injections. Arch Neurol 48:1253\u20131256","journal-title":"Arch Neurol"},{"key":"97_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10659","volume":"19","author":"P Haussermann","year":"2004","unstructured":"Haussermann P, Marczoch S, Klinger C et al (2004) Long-term follow-up of cervical dystonia patients treated with botulinum toxin type A. Mov Disord 19:303\u2013308","journal-title":"Mov Disord"},{"key":"97_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","volume":"2","author":"JKC Tsui","year":"1986","unstructured":"Tsui JKC, Eisen A, Stoessl AJ et al (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2:245\u2013247","journal-title":"Lancet"},{"key":"97_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/mds.20024","volume":"19","author":"J Jankovic","year":"2004","unstructured":"Jankovic J (2004) Treatment of cervical dystonia with botulinum toxin. Mov Disord 19:109\u2013115","journal-title":"Mov Disord"},{"key":"97_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00702-007-0831-4","volume":"15","author":"CL Comella","year":"2008","unstructured":"Comella CL (2008) The treatment of cervical dystonia with botulinum toxins. J Neural Transm 15:579\u2013583","journal-title":"J Neural Transm"},{"key":"97_CR9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870120117","volume":"12","author":"D Tarsy","year":"1997","unstructured":"Tarsy D (1997) Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 12:100\u2013102","journal-title":"Mov Disord"},{"key":"97_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S0317167100052240","volume":"27","author":"PK Pal","year":"2000","unstructured":"Pal PK, Samii A, Schulzer M et al (2000) Head tremor in cervical dystonia. Can J Neurol Sci 27:137\u2013142","journal-title":"Can J Neurol Sci"},{"key":"97_CR11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/mds.870130319","volume":"13","author":"E Molho","year":"1998","unstructured":"Molho E, Feustel PJ, Factor SA (1998) Clinical comparison of tardive and idiopathic dystonia. Mov Disord 13:486\u2013489","journal-title":"Mov Disord"},{"key":"97_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000109265","volume":"59","author":"S Papapetropoulos","year":"2008","unstructured":"Papapetropoulos S, Baez S, Zitser J et al (2008) Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors. Eur Neurol 59:71\u201375","journal-title":"Eur Neurol"},{"key":"97_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.20022","volume":"19","author":"D Dressler","year":"2004","unstructured":"Dressler D (2004) Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov Disord 19:92\u2013100","journal-title":"Mov Disord"},{"key":"97_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","volume":"246","author":"KR Kessler","year":"1999","unstructured":"Kessler KR, Skutta M, Benecke R (1999) Long-term treatment of cervical dystonia with botulinum toxin type A: efficacy, safety, and antibody frequency. J Neurol 246:265\u2013274","journal-title":"J Neurol"},{"key":"97_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2004.01053.x","volume":"12","author":"IM Skogseid","year":"2005","unstructured":"Skogseid IM, Kerty E (2005) The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 12:163\u2013170","journal-title":"Eur J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0097-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-009-0097-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0097-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:11:40Z","timestamp":1559121100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-009-0097-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,26]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["97"],"URL":"https:\/\/doi.org\/10.1007\/s10072-009-0097-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,26]]}}}